References
- KakinokiSTaguchiTAntitumor effect of an injectable in-situ forming drug delivery system composed of a novel tissue adhesive containing doxorubicin hydrochlorideEur J Pharm Biopharm20076767668117493793
- LeeFChungJEKurisawaMAn injectable hyaluronic acid-tyramine hydrogel system for protein deliveryJ Control Release200913418619319121348
- FraylichMRLiuRRichardsonSMThermally-triggered gelation of PLGA dispersions: towards an injectable colloidal cell delivery systemJ Colloid Interface Sci2010344616920070971
- HollisterLESite-specific drug delivery to CNS: Old and newNeurobiol Aging198910628631
- LevyRJVinodLStrickbergerSAUnderwoodTDavisJControlled release implant dosage forms for cardiac arrhythmias: review and perspectivesDrug Delivery19963137142
- TiptonAJDunnRLIn situ gelling systemsSeniorJRadomskyMSustained Release Injectable ProductsEnglewood, COInterpharm Press200071102
- HatefiAAmsdenBBiodegradable injectable in situ forming drug delivery systemsJ Control Release20028092811943384
- PackhaeuserCBSchniedersJOsterCGKisselTIn situ forming parenteral drug delivery systems: an overviewEur J Pharm Biopharm20045844545515296966
- DunnRLEnglishJPCowsarDRVanderbiltDP inventorsBiodegradable in-situ forming implants and methods of producing the samePatent57339501998331
- RavivarapuHBMoyerKLDunnRLSustained suppression of pituitary-gonadal axis with an injectable, in situ forming implant of leuprolide acetateJ Pharml Sci200089732741
- RavivarapuHBMoyerKLDunnLParameters affecting the efficacy of a sustained release polymeric implant of leuprolideInt J Pharm200019418119110692642
- LambertWJPeckKDDevelopment of an in situ forming biodegradable poly-lactide-co-glycolide system for the controlled release of proteinsJ Control Release199533189195
- WangLKleinerLVenkatramanSStructure formation in injectable poly(lactide-co-glycolide) depotsJ Control Release20039034535412880701
- KumariAKumarYSYadavSCBiodegradable polymeric nanoparticles based drug delivery systemsColloids Surf B Biointerfaces20107511819782542
- LuanXBodmeierRInfluence of the poly(lactide-co-glycolide) type on the leuprolide release from in situ forming microparticle systemsJ Control Release200611026627216300851
- RoyRKA Primer on the Taguchi MethodNew YorkVan Nostrand Reinhold1990
- FisherRAThe Design of Experiments8th edNew YorkHafner Press1966
- AshrafizadehSNKhorasaniZAmmonia removal from aqueous solutions using hollow-fiber membrane contactorsChem Eng J2010162242249
- KuoHCJengMCEffects of part geometry and injection molding conditions on the tensile properties of ultra-high molecular weight polyethylene polymerMater Des201031884893
- ParkSHRobust design and Analysis for Quality EngineeringLondon, UKChapman and Hall1996
- MadaeniSSKoochekiSApplication of taguchi method in the optimization of wastewater treatment using spiral-wound reverse osmosis elementChem Eng J20061193744
- JosephRMcGregorWJMartynMTTannerKECoatesPDEffect of hydroxyapatite morphology/surface area on the rheology and processability of hydroxyapatite filled polyethylene compositesBiomaterials2002234295430212194532
- BirnbaumDTKosmalaDHenthornBPeppasBControlled release of beta-estradiol from PLAGA microparticles: the effect of organic phase solvent on encapsulation and releaseJ Control Release20006537538710699296
- OtsukaMUdenodanHMatsudaYTherapeutic effect of in vivo sustained estradiol release from poly (lactide-co-glycolide) microspheres on bone mineral density of osteoporosis ratsBiomed Mater Eng20021215716712122239
- BeseAVBoruluNCopurMColakSNuri AtaOOptimization of dissolution of metals from Waelz sintering waste (WSW) by hydrochloric acid solutionsChem Eng J2010162718722
- AtkinsPWPhysical Chemistry4th edOxford, UKOxford University Press1990
- KempeSMetzHMaderKDo in situ forming PLG/NMP implants behave similar in vitro and in vivo? A non-invasive and quantitative EPR investigation on the mechanisms of the implant formation processJ Control Release200813022022518611421
- XuQCzernuszkaJTControlled release of amoxicillin from hydroxyapatite-coated poly(lactic-co-glycolic acid) microspheresJ Control Release200812714615318325617
- LinPLFangHWTsengTLeeWHEffects of hydroxyapatite dosage on mechanical and biological behaviors of polylactic acid composite materialsMater Lett20076130093013
- EliazREWallachDKostJDelivery of soluble tumor necrosis factor receptor from in-situ forming PLGA implants: in-vivoPharm Res2000171546155011303966
- BarakatNSOptimization of physical characterization, skin permeation of naproxen from glycofurol-based topical gelAsian J Pharm20104154162
- AllhennDLamprechtAMicrosphere preparation using the untoxic solvent glycofurolPharm Res20111156357121049282
- BarakatNEvaluation of glycofurol-based gel as a new vehicle for topical application of naproxenAAPS Pharm Sci Tech20101111381146
- IwamotoRAmiyaSSaitoYSamuraHFT-NIR spectroscopic study of OH groups in ethylene-vinyl alcohol copolymerAppl Spectrosc200155864870
- SuitchmezianVJessINatherCInvestigations on the polymorphism and pseudopolymorphism of the glucocorticoid triamcinolone: new findings for a well-known drugCryst Growth Des200776974
- da SilvaAAde MatosJRFormarizTPThermal behavior and stability of biodegradable spray-dried microparticles containing triamcinoloneIntl J Pharm20093684555
- YoungTHChuangWYWeiCWTangCYInvestigation of the drug distribution and release characteristics from particulate membranesJ Memb Sci2001191199205
- StamatialisDFPapenburgBJGironesMMedical applications of membranes: drug delivery, artificial organs and tissue engineeringJ Memb Sci2008308134
- MaDMcHughAJThe interplay of phase inversion and membrane formation in the drug release characteristics of a membrane-based delivery systemJ Memb Sci2007298156168
- XiangAMaDMcHughAJThe interplay of phase inversion, polymer membrane formation, and drug release in a membrane-based delivery systemJ Memb Sci20103588592
- McHughAJThe role of polymer membrane formation in sustained release drug delivery systemsJ Control Release200510921122116288815